Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
celgene
5
×
clinical trials
5
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
eli lilly
fda
johnson & johnson
pfizer
biotech
bristol-myers squibb
gene therapy
genentech
sarepta therapeutics
abbvie
astrazeneca
avexis
What
bio
roundup
5
×
news
companies
drug
fda
known
nash
week
aducanumab
alzheimer’s
amyloid
angst
approved
arena’s
august
bagged
billions
biogen
biogen’s
biopharma
biotech
bounty
brammer
busy
cig
comeback
congress
congressional
corner
crispr
days
deals
decisions
delivered
devices
digital
disease
drugs
effects
Language
unset
Current search:
roundup
×
celgene
×
" clinical trials "
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
